162 related articles for article (PubMed ID: 28167198)
1. Analysis of serum interleukin-27 and interleukin-35 concentrations in patients with Guillain-Barré syndrome.
Zhang LJ; Guo HY; Zhang DQ; Wang R; Li T; Li LM; Suo DM; Yang L
Clin Chim Acta; 2017 May; 468():5-9. PubMed ID: 28167198
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.
Wang XK; Zhang HL; Meng FH; Chang M; Wang YZ; Jin T; Mix E; Zhu J
Neurol Sci; 2013 May; 34(5):655-61. PubMed ID: 22526766
[TBL] [Abstract][Full Text] [Related]
3. The role of IL-12 and TNF-alpha in AIDP and AMAN.
Deng H; Yang X; Jin T; Wu J; Hu LS; Chang M; Sun XJ; Adem A; Winblad B; Zhu J
Eur J Neurol; 2008 Oct; 15(10):1100-5. PubMed ID: 18717726
[TBL] [Abstract][Full Text] [Related]
4. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
[TBL] [Abstract][Full Text] [Related]
5. Altered serum levels of IL-36 cytokines (IL-36α, IL-36β, IL-36γ, and IL-36Ra) and their potential roles in Guillain-Barré syndrome.
Zhao Z; Zhang R; Gao X; Li H; Liu H
Medicine (Baltimore); 2020 Dec; 99(52):e23832. PubMed ID: 33350771
[TBL] [Abstract][Full Text] [Related]
6. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barré syndrome.
Umapathi T; Li Z; Verma K; Yuki N
Clin Neurophysiol; 2015 Dec; 126(12):2376-80. PubMed ID: 25743269
[TBL] [Abstract][Full Text] [Related]
7. IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barré syndrome.
Li S; Yu M; Li H; Zhang H; Jiang Y
Mediators Inflamm; 2012; 2012():260473. PubMed ID: 23091305
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Guillain-Barre syndrome in children: results from a Mexican population.
Nachamkin I; Arzarte Barbosa P; Ung H; Lobato C; Gonzalez Rivera A; Rodriguez P; Garcia Briseno A; Cordero LM; Garcia Perea L; Perez JC; Ribera M; Aldama PC; Guitérrez GD; Sarnat LF; García MR; Veitch J; Fitzgerald C; Cornblath DR; Rodriguez Pinto M; Griffin JW; Willison HJ; Asbury AK; McKhann GM
Neurology; 2007 Oct; 69(17):1665-71. PubMed ID: 17898327
[TBL] [Abstract][Full Text] [Related]
9. Elevated cerebrospinal fluid levels of beta-2-microglobulin in patients with Guillain-Barré syndrome and their correlations with clinical features.
Liu MQ; Wang J; Huang CN; Qi Y; Zhang LJ; Yi M; Chang SH; Sun LS; Yang L
Neurol Sci; 2021 Oct; 42(10):4249-4255. PubMed ID: 33598798
[TBL] [Abstract][Full Text] [Related]
10. Increased serum concentrations of transforming growth factor-β1 (TGF-β1) in patients with Guillain-Barré syndrome.
Chang KH; Lyu RK; Ro YS; Chen YC; Ro LS; Chang HS; Huang CC; Liao MF; Wu YR; Kuo HC; Chu CC; Chen CM
Clin Chim Acta; 2016 Oct; 461():8-13. PubMed ID: 27450064
[TBL] [Abstract][Full Text] [Related]
11. Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria.
Hosokawa T; Nakajima H; Unoda K; Yamane K; Doi Y; Ishida S; Kimura F; Hanafusa T
J Neurol; 2016 Sep; 263(9):1709-18. PubMed ID: 27278064
[TBL] [Abstract][Full Text] [Related]
12. [Electrophysiological subtypes and long term prognosis of Guillain-Barré syndrome].
Zhang J; Song XJ; Hou HQ; Tan GJ; Bian GY; Li B; Chen LP; Wang L; Guo L
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(25):1987-90. PubMed ID: 27470955
[TBL] [Abstract][Full Text] [Related]
13. A multicentre prospective study of Guillain-Barré syndrome in Japan: a focus on the incidence of subtypes.
Mitsui Y; Kusunoki S; Arimura K; Kaji R; Kanda T; Kuwabara S; Sonoo M; Takada K;
J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):110-4. PubMed ID: 24273220
[TBL] [Abstract][Full Text] [Related]
14. Increased Cerebrospinal Fluid Uric Acid Levels in Guillain-Barré Syndrome.
Chang SH; Tian XB; Wang J; Liu MQ; Huang CN; Qi Y; Zhang LJ; Gao CL; Zhang DQ; Sun LS; Yang L
Front Neurol; 2020; 11():589928. PubMed ID: 33281729
[TBL] [Abstract][Full Text] [Related]
15. IL-23 and IL-27 Levels in Serum are Associated with the Process and the Recovery of Guillain-Barré Syndrome.
Peng J; Zhang H; Liu P; Chen M; Xue B; Wang R; Shou J; Qian J; Zhao Z; Xing Y; Liu H
Sci Rep; 2018 Feb; 8(1):2824. PubMed ID: 29434217
[TBL] [Abstract][Full Text] [Related]
16. Cav2.1 voltage-dependent Ca2+ channel current is inhibited by serum from select patients with Guillain-Barré syndrome.
Nakatani Y; Hotta S; Utsunomiya I; Tanaka K; Hoshi K; Ariga T; Yu RK; Miyatake T; Taguchi K
Neurochem Res; 2009 Jan; 34(1):149-57. PubMed ID: 18478327
[TBL] [Abstract][Full Text] [Related]
17. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy.
Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Naldi P; Molinari R; Monaco F; Avanzi GC
Cytokine; 2010 Aug; 51(2):138-43. PubMed ID: 20538476
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome: subtypes and predictors of outcome from India.
Kalita J; Misra UK; Goyal G; Das M
J Peripher Nerv Syst; 2014 Mar; 19(1):36-43. PubMed ID: 24456386
[TBL] [Abstract][Full Text] [Related]
19. [Classification of pregnancy complicating Guillain-Barré syndrome].
Gu YW; Lin J; Zhang LX; Liang XM; Fan HG; Zhao L; Wang LJ; Yang L
Zhonghua Yi Xue Za Zhi; 2019 May; 99(18):1401-1405. PubMed ID: 31137128
[No Abstract] [Full Text] [Related]
20. [Follow-up study on the clinical characteristics and treatment effect of the different types of Guillain-Barré syndrome in children].
Wang XH; Zou LP; Wu HS; Fang F; Lü JL; Xiao J; Ding CH; Chen CH; Wang X; Jin H; Zhou WM; Cai FY
Zhonghua Er Ke Za Zhi; 2011 Aug; 49(8):583-8. PubMed ID: 22093419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
